Developing regions vs Norway: Proportion of the target population who received the final dose of
Developing regions
26.0%
in 2024
Norway
91.0%
in 2024
Developing regions rank
10th
Norway rank
8th
Proportion of the target population who received the final dose of over time
- Developing regions
- Norway
How they compare
Norway currently reports 91.0% against 26.0% in Developing regions, a difference of 65.0%.
That makes Norway's figure about 3.5 times Developing regions's.
Across all 15 years both countries report, Norway has been ahead every year.
Developing regions ranks 10th and Norway ranks 8th of 13 groups.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.4% | 78.5% | 73.1% | Norway |
| 2020s | 14.0% | 90.6% | 76.6% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Developing regions or Norway?
- Norway, at 91.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Developing regions and Norway?
- 65.0%, with Norway ahead.
- How many years of comparable data are there for Developing regions and Norway?
- 15 years are reported by both, from 2010 to 2024.
- How do Developing regions and Norway rank globally for proportion of the target population who received the final dose of?
- Developing regions ranks 10th and Norway ranks 8th of 13 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.